Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKX-001 in Islet Transplantation
NCT03073577Phase 1Completed
- Sponsor
- University of Alberta
- Start
- Feb 2017
- Primary completion
- May 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PKX-001 in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Primary endpoints: Adverse event morbidity at 1 year and Serious adverse event morbidity at 1 year. Started Feb 2017; status: completed.
02
Drugs
PKX-001
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03073577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073577.